On this page

Dose Insider / Outsourcing pharmacies

FDA-registered outsourcing pharmacies: all 100, with their inspections

FDA list of November 17, 2026 · checked against fda.gov on November 20, 2026

100 compounding pharmacies are registered with FDA as 503B outsourcing facilities as of November 17, 2026. FDA has inspected 57 of them as outsourcing facilities and issued a Form 483 after 56 of those inspections; the median report lists 5 observations.

Each facility has a page with its registration dates, its last inspection, what the inspectors observed and any FDA warning letter about GLP-1 drugs that names it. Every fact comes from FDA’s list and the reports FDA posted with it.1

Is the pharmacy behind my prescription on FDA’s list?

Type a pharmacy name or city. A 503A pharmacy that compounds for individual prescriptions is licensed by its state and is not on this list.

Pharmacy check100 facilities
Registered 503B—
With a Form 483—

Where are they?

Texas has the most registered facilities, 17, followed by Florida with 16.

Facilities by stateFDA list, November 17, 2026
Show
Facilities—
Top state—

All 100 facilities

FacilityStateLast inspectionForm 483
503B Outsourcing Facility One, LLCFLNot yetNo
Ajenat Pharmaceuticals, LLCFLNot yetNo
AnazaoHealth CorporationNV2025-08-084 observations
Annovex Pharma, Inc.VA2026-06-032 observations
Apertus Compounding, LLCMONot yetNo
Apocus, Inc.TXNot yetNo
Apollo CareMO2026-07-287 observations
Apothecary Pharma, LLCNC2026-09-02Issued
Arc Compounding Pharmacy, LLCTXNot yetNo
Aspire Compounding PharmacyTXNot yetNo
Assure Infusions, Inc.FL2026-09-17Issued
Atilar Pharma CorporationTXNot yetNo
Aveva Drug Delivery Systems, IncFLNot yetNo
BayCare Integrated Service Center, LLC dba BayCare Central PharmacyFL2026-03-129 observations
Bennett Pharmaceuticals of America LLCWINot yetNo
Bespoke Pharmaceutical, LLCNVNot yetNo
BPI Labs LLCFL2026-04-174 observations
Bravado Pharmaceuticals, LLCFLNot yetNo
Brookfield Medical/Surgical Supply, Inc.CT2026-07-104 observations
BSO LLCCO2026-11-13Issued
BSO LLCCO2025-07-169 observations
Central Admixture Pharmacy Services, Inc.PA2025-09-055 observations
Central Admixture Pharmacy ServicesAZ2025-09-058 observations
Delta Pharma, Inc.MS2025-11-212 observations
Denver Solutions, LLC, dba Leiters HealthCO2025-12-117 observations
Denver Solutions, LLC, dba Leiters HealthNJNot yetNo
Eagle PharmaAL2026-09-29Issued
Empower Clinic Services New JerseyNJNot yetNo
Empower PharmaTX2025-11-146 observations
F.H. Investments, Inc.AL2025-12-1910 observations
Farmakeio Outsourcing LLCTX2025-09-055 observations
Fagron Compounding Services dba Fagron Sterile ServicesKS2025-08-086 observations
Fresenius Kabi Compounding LLC dba Fagron Sterile ServicesMA2025-11-057 observations
Galaxy Pharmaceuticals, LLCNYNot yetNo
GenoGenix LLCFL2025-07-1816 observations
GFC Pharma, LLCMDNot yetNo
Hyalo Technologies Limited Liability CompanyNJNot yetNo
Hybrid Pharma, LLCCA2026-08-27Issued
Imprimis NJOF, LLCNJ2026-08-186 observations
IntegraDose Compounding Services, LLCMN2026-08-124 observations
Leesar Inc.FL2026-09-28Issued
Mark Cuban Cost Plus Manufacturing and Compounding, LLCTX2026-09-30Issued
Maxhealth Group, LLC dba New Life RxTXNot yetNo
McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing SolutionsCANot yetNo
Medi-Fare DrugSC2025-06-069 observations
Medicinal Sciences Ltd. Co.TXNot yetNo
MedisourceRxCA2025-06-102 observations
Molecular PharmaGroupNJ2026-11-13Issued
Navasha Pharma Labs LimitedPANot yetNo
Navinta III Inc.FLNot yetNo
Nephron Sterile Compounding Center, LLC (NSCC)SC2025-08-226 observations
Nexgen FormulationsPANot yetNo
Nivagen Pharmaceuticals, LLCCANot yetNo
NLRx, LLCTNNot yetNo
Nubratori, Inc.CA2025-12-113 observations
Ocyon Bio PR, LLCPRNot yetNo
Olympia PharmaceuticalsFL2026-09-038 observations
Olyx PharmaTXNot yetNo
Orion Specialty Labs, LLCNot yetNo
OSRX, Inc.MT2025-11-144 observations
OurPharma LLCAR2026-08-123 observations
Park Avenue CompoundingMO2025-09-23Issued
PGRrx LLCPANot yetNo
Pine Pharmaceuticals, LLCNY2025-11-144 observations
PQ Pharmacy LLCFL2026-06-017 observations
ProRx LLCPA2026-11-10Issued
Qualgen LLCOK2025-09-045 observations
Quantum Pharmaceuticals, LLCOKNot yetNo
Quva Pharma, Inc.NJ2026-11-13Issued
Quva Pharma, Inc.TX2026-05-043 observations
RC Outsourcing, LLCOH2026-09-038 observations
Rapha Pharmaceuticals, lnc.NVNot yetNo
Right Value Drug Stores, LLC, dba Carie Boyd's Prescription ShopTX2026-09-086 observations
Sankav Pharmaceuticals, LLCNJNot yetNo
SCA PharmaceuticalsAR2025-10-304 observations
SCA PharmaceuticalsCT2026-03-133 observations
Signature RxFLNot yetNo
Simple RX Solutions, P.C.TNNot yetNo
SKNV formerly registered as Sincerus Florida, LLCFL2026-05-297 observations
STAQ Pharma, Inc.CO2026-09-08Issued
STAQ Pharma of Ohio, LLCOH2026-08-193 observations
Staska Pharmaceuticals, Inc.NE2026-02-203 observations
Stokes Healthcare Inc., dba Epicur PharmaNJ2025-05-2310 observations
Strive Outsourcing LLCFLNot yetNo
Tailstorm Health Inc.AZ2026-08-284 observations
Turbare ManufacturingAR2026-05-074 observations
University of TennesseeTNNot yetNo
US Specialty Formulations LLCPA2026-01-147 observations
Vitae Enim Vitae Scientific, Inc.CANot yetNo
VitalRx Pharmacy, LLCTXNot yetNo
WeCare Pharmaceutical Corp dba WeCare PharmaceuticalsVANot yetNo
Wedgewood Connect, LLC, formerly registered as Leiter's CompoundingCA2025-07-03Issued
Wedgewood Connect Ohio, LLCOHNot yetNo
Wells Pharma of Houston, LLCTX2026-04-136 observations
Wells Pharmacy, Inc.TN2026-04-092 observations
White Label Pharmacy dba Nova PharmacyTXNot yetNo
Wesley PharmaceuticalsFL2026-03-16No
Wilcrest Pharmaceuticals, Inc.TXNot yetNo
Willowbend Pharma Select, LLCTXNot yetNo
Xseer Pharmaceuticals, Inc.CANot yetNo

What does it mean that a pharmacy is a 503B outsourcing facility?

An outsourcing facility is a compounder that has chosen to register with FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. It must re-register every year between October 1 and December 31 and pay an annual fee; a facility that does not is removed from FDA’s list on January 1.1 Once registered, it joins the list of facilities FDA plans to inspect on a risk-based schedule.1

A Form FDA 483 lists what investigators observed during an inspection. FDA states that a 483 is issued when investigators see significant objectionable conditions, and that it is not a final agency determination that the law was broken.1 Registration is not FDA approval of the drugs a facility makes: compounded drugs are not FDA-approved.

How was this list built?

On November 20, 2026 we read FDA’s table of registered outsourcing facilities, updated November 17, 2026, downloaded each Form 483 FDA links from it, and counted the observations in each report. We sorted observations into topics by the words of their opening sentence. The contact names and phone numbers in FDA’s table are left out. Nothing here comes from other review sites.

Sources

  1. FDA. Facilities registered as human drug compounding outsourcing facilities under section 503B, updated November 17, 2026, with its notes on registration and inspections. fda.gov

Log every dose in mg with the vial it came from, so there is a record if something goes wrong.

Open Dose Insider